This HTML5 document contains 213 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12https://scigraph.springernature.com/pub.10.1186/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42006157
rdf:type
wikibase:Item
schema:description
2014年論文 2014年の論文 2014年论文 επιστημονικό άρθρο videnskabelig artikel artigo científico 2014年論文 vedecký článok scientific article published on 26 October 2014 artikel ilmiah ২৬ অক্টোবর ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artikull shkencor article scientifique tieteellinen artikkeli научна статия article scientific artículo científico publicado en 2014 2014 nî lūn-bûn 2014年論文 vědecký článek bài báo khoa học vitenskapelig artikkel artigo científico מאמר מדעי 2014年論文 article científic scientific article published on 26 October 2014 наукова стаття, опублікована в жовтні 2014 2014年论文 bilimsel makale naučni članak vitskapeleg artikkel artigo científico 2014年論文 სამეცნიერო სტატია articol științific 2014年论文 scientific article published on 26 October 2014 научни чланак wetenschappelijk artikel scienca artikolo artikulong pang-agham научная статья artículu científicu espublizáu en 2014 мақолаи илмӣ مقالة علمية نشرت في 26 أكتوبر 2014 2014年论文 teaduslik artikkel 2014年论文 wissenschaftlicher Artikel 2014년 논문 tudományos cikk научни чланак vetenskaplig artikel บทความทางวิทยาศาสตร์ articolo scientifico artykuł naukowy 2014年论文
p:P577
wds:Q42006157-1196F1BA-10A3-4693-9AF8-B39BB6D8AC15
wdt:P577
2014-10-26T00:00:00Z
p:P407
wds:Q42006157-F586821E-5D2E-4135-95D5-B2B5F5980F54
wdt:P407
wd:Q1860
p:P2888
wds:Q42006157-1CD0C0A8-5C70-476A-B489-58F9BB25E360
wdt:P2888
n12:s12933-014-0148-1
p:P2860
wds:Q42006157-F2641970-F238-4F8E-8B73-8F4370392D29 wds:Q42006157-BF69B71F-AF88-4F08-99BC-565A6FDBDB67 wds:Q42006157-C0C9C47D-379C-4375-830E-E576270D9196 wds:Q42006157-C23AAE10-8BB6-4150-87DD-55797889B829 wds:Q42006157-DFBBB104-3619-4883-9B85-021FF894E28E wds:Q42006157-E0A0FD7F-0956-46D5-A0A1-32801535638E wds:Q42006157-E60E071B-E62C-4079-92E1-238ECA2A3A4A wds:Q42006157-FD43279F-6371-440C-BC7A-2FC9BC9CF7C4 wds:Q42006157-01CF8801-44EE-430D-9D6B-43451ED47A22 wds:Q42006157-09AA4159-25DF-4031-BEBE-C20686BD6085 wds:Q42006157-0B7DB22B-45E7-4A04-9813-61542AF5F89B wds:Q42006157-0D01F166-57F7-46C2-9E71-2C5C032C8F50 wds:Q42006157-298C31B1-BBCE-41DB-86E6-C69D4E3B224C wds:Q42006157-2CC04C4B-4617-4BEA-99FF-7ECB8FC7D371 wds:Q42006157-30D5BFC9-9E60-4EAF-A6DC-528F6DE9D927 wds:Q42006157-32B16790-437E-4A41-88F7-2D374035F9A1 wds:Q42006157-35093B12-E1C4-4338-9FC2-F861B70AFA8E wds:Q42006157-3618CDBB-273A-40D3-8275-148BEA443B30 wds:Q42006157-38A54418-C174-49CF-9B3C-39D26EEDA6AD wds:Q42006157-39420FB4-B906-45D7-B25C-CBE97788F8B1 wds:Q42006157-145CA5B1-1BCB-41D9-B424-5110AA187018 wds:Q42006157-18EF0AF3-159E-411A-BECA-291EE178CC6D wds:Q42006157-1A88E5E9-6E98-419A-B164-AB6DF123326F wds:Q42006157-1D477D57-6834-4307-83FF-02E5F295F0B1 wds:Q42006157-20DD88BE-C99F-4018-8AD5-13AF737F3439 wds:Q42006157-706FCDEE-5CC8-4BAB-BE58-11227803F2F6 wds:Q42006157-75ABCBF4-BA46-430C-8724-358EB4AA2A19 wds:Q42006157-7687A19E-3270-4169-880E-0698E1BDBB04 wds:Q42006157-7690AB9D-F997-403B-8C62-06677EE983B6 wds:Q42006157-41F2DB5F-629C-4836-B750-0CB83C9A70EE wds:Q42006157-47B6E122-FF15-481A-B335-6A5FBF350F56 wds:Q42006157-47D39DE1-4BCD-4EDE-9625-29DEF66383D9 wds:Q42006157-6858DD11-21AD-4212-AF82-3E177B13DA9F wds:Q42006157-688DF7B6-D664-4285-97C5-F342BF964DEB wds:Q42006157-A36F42A8-8215-41A9-BF7E-359F8B5C4F12 wds:Q42006157-AAF4F34B-3615-4846-976B-1870DAFA91C9 wds:Q42006157-ACC49189-308D-4D35-8CDC-60C468424F6D wds:Q42006157-B6FF9B0B-8B13-4691-9283-A958151F8770 wds:Q42006157-BBFE9EB1-8956-4C4B-AAE8-030AEBEE1CC8 wds:Q42006157-87DB3A6B-849C-4514-BC4B-428943228DF7 wds:Q42006157-8907425E-D85F-4B20-87DA-B7E6E5B62B77 wds:Q42006157-950F2A60-E10A-480B-9085-0E7352316956 wds:Q42006157-E7AC7A3B-C3C2-4A7C-84CB-DF79DDB97D5D wds:Q42006157-E820E443-3D72-49B5-911E-00E6C3AAA5D7 wds:Q42006157-E86FAF2F-E144-4872-BEC6-CD1D017A006E
wdt:P2860
wd:Q46805139 wd:Q48938864 wd:Q87809056 wd:Q34222752 wd:Q38114531 wd:Q36440333 wd:Q46931627 wd:Q34458197 wd:Q35950244 wd:Q43247372 wd:Q37981884 wd:Q42165604 wd:Q42925710 wd:Q37989674 wd:Q43253149 wd:Q38306298 wd:Q51366978 wd:Q29547736 wd:Q37575455 wd:Q73224794 wd:Q37351709 wd:Q28297680 wd:Q46396191 wd:Q38195478 wd:Q24652963 wd:Q35194026 wd:Q28297690 wd:Q30457872 wd:Q37219076 wd:Q36828139 wd:Q34083053 wd:Q44779281 wd:Q33837017 wd:Q35043454 wd:Q28346436 wd:Q34031315 wd:Q51330257 wd:Q24608301 wd:Q36852567 wd:Q42524355 wd:Q80224070 wd:Q35157497 wd:Q29615973 wd:Q38196149 wd:Q36693221
p:P2093
wds:Q42006157-A46DF603-1D23-415A-BD03-B44E68D39576 wds:Q42006157-A50D7F3B-D59E-43D1-AE2D-695F9E314591 wds:Q42006157-9505ACC5-670B-430E-A554-C3642C83F8C1 wds:Q42006157-845680C2-096E-4345-856A-944E583CD38C wds:Q42006157-7E21D59E-6949-41F7-91F6-E4888154AA0B wds:Q42006157-4B0A65E7-8A45-4DF3-B5A4-35EDC36BF957 wds:Q42006157-3F421203-1C57-48E0-9AAB-5FC39385ACF5 wds:Q42006157-F6431D87-B469-4CD8-A86E-809A261CD7DE wds:Q42006157-E5F1000A-9D95-41B2-9F22-F11A4623F2FC wds:Q42006157-C4A330EA-31A7-4DB5-B243-480C84F63D19
wdt:P2093
Shokei Kim-Mitsuyama Nobutaka Koibuchi Takashi Nakagawa Kensuke Toyama Yu Hasegawa Bowen Lin MingJie Ma Daisuke Sueta Ken Uekawa Hiroaki Kusaka
rdfs:label
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
skos:prefLabel
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
schema:name
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
p:P1476
wds:Q42006157-6FC33E74-A83E-4767-AEF1-5E23BE65EF3E
wdt:P1476
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
p:P304
wds:Q42006157-FF13B8B2-578A-4049-850C-A2F730D6239A
wdt:P304
148
p:P31
wds:Q42006157-90EEBE97-E5CC-4FBA-B391-D5077E19C307
wdt:P31
wd:Q13442814
p:P921
wds:Q42006157-A28AC082-9D1A-49C6-9F34-03118941EBC7 wds:Q42006157-0D7460E8-F79B-4985-9517-FD424220F927 wds:Q42006157-0894AA4A-3109-4B5C-8273-2A2B2CCA09C7
wdt:P921
wd:Q57859955 wd:Q12174 wd:Q11068
p:P698
wds:Q42006157-88E1C9C7-052D-4634-BF6E-DF5625605C9E
wdtn:P698
n8:25344694
wdt:P698
25344694
p:P1433
wds:Q42006157-474E221F-87DA-45A7-B1BB-181579B991EB
wdt:P1433
wd:Q2468083
p:P478
wds:Q42006157-8EEED7A8-45B9-4FAC-BF9E-343436C8E2B6
wdt:P478
13
p:P356
wds:Q42006157-1738B3B6-13D8-4BA9-B074-7FA7FCA2C1B8
wdtn:P356
n11:S12933-014-0148-1
wdt:P356
10.1186/S12933-014-0148-1
p:P275
wds:Q42006157-792e429d-974b-4dfe-90a2-0035d53897b5
p:P6216
wds:Q42006157-c36fddb5-18f8-4440-9e26-fb46e245bb40
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P5875
wds:Q42006157-F3A4D541-0DBC-4E95-90BA-348CC8C7DE4B
wdt:P5875
267743949
p:P6179
wds:Q42006157-F463B767-C0A1-4027-8287-F23A5CD689B6
wdt:P6179
1022419393
p:P932
wds:Q42006157-7790059A-C4FB-4AB4-8CB0-4A6D1D3BCE5A
wdt:P932
4219031